Award
NIH Reporter #5R01CA227942-25
Targeting the cancer glycocalyx
Recipient
Stanford University, CA, United States
Award Amount
$503,708.00
Ceiling
$503,708.00
Awarded
April 13, 2026
Identifier
5R01CA227942-25
The award supports research to understand how cancer cell-surface sugars contribute to disease progression and to develop new therapies targeting these sugars, including targeted mucin degraders and antibody-lectin chimeras.
Description
This project focuses on understanding cancer cell surface sugars and developing innovative therapies targeting the cancer glycocalyx, with potential for preclinical development of new cancer treatments.